Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Increase in Short Interest

by · The Markets Daily

Ocean Biomedical, Inc. (NASDAQ:OCEAW – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 8,400 shares, a growth of 250.0% from the September 30th total of 2,400 shares. Based on an average daily volume of 48,900 shares, the days-to-cover ratio is presently 0.2 days.

Ocean Biomedical Price Performance

Shares of Ocean Biomedical stock remained flat at $0.05 during trading hours on Friday. The stock had a trading volume of 8,498 shares, compared to its average volume of 43,124. Ocean Biomedical has a twelve month low of $0.02 and a twelve month high of $0.70. The firm has a 50-day simple moving average of $0.04 and a 200-day simple moving average of $0.06.

About Ocean Biomedical

(Get Free Report)

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.

Further Reading